SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
hhhhh
Lv1
20 积分
2024-08-30 加入
最近求助
最近应助
互助留言
Pembrolizumab followed by irreversible electroporation of a liver metastasis in pancreatic cancer patients
5小时前
待确认
Pre‐diagnostic plasma inflammatory proteins and risk of hepatocellular carcinoma in three population‐based cohort studies from the United States and the United Kingdom
5小时前
已完结
Resistance to anti-PD-1/anti-PD-L1: galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1
1个月前
已完结
Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8+T cell-mediated antitumour immunity and improves anti-PD-1 efficacy
1个月前
已完结
Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy
1个月前
已完结
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): a phase 2, randomized, controlled trial
1个月前
已完结
没有进行任何应助
感谢
5小时前
感谢
1个月前
感谢
1个月前
感谢
1个月前
感谢
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论